18.02.2025 10:24:00

Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?

After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. From the end of 2024 through Feb. 14, the stock climbed 46.7% higher.Shares of the healthcare conglomerate stock notched significant gains after management presented an encouraging fourth-quarter earnings report on Wednesday, Feb. 12. Adjusted earnings that reached $1.19 per share were 29% above the average estimate from Wall Street analysts who follow the company.CVS Health stock is way up but still offers a juicy 4% dividend yield at recent prices. Could it be a smart buy now for income-seeking investors? Below, I'll weigh some of the company's strengths against its weaknesses to find out.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu CVS Health Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

CVS Health Corp 63,34 -0,52% CVS Health Corp